劲方医药科技（上海）股份有限公司（股票名称：劲方医药-B，股票代码：02595）于2026年5月7日披露了截至2026年4月30日的证券变动月报表。报告显示，公司本月已发行股本数与上月相比无变化，股本维持稳定。
公告披露，公司注册资本由两部分组成：H股338,029,020股，面值人民币0.1元，合计人民币33,802,902元；未上市普通股32,337,610股，面值人民币0.1元，合计人民币3,233,761元。两者合计股数为370,366,630股，注册股本总额人民币37,036,663元，与上月底持平。
报告期内，劲方医药-B未有任何新增发行、回购或注销股份活动，也不存在库藏股数量变动。此外，本期无涉及股份期权计划、股权激励计划或可换股票据等相关变动，亦无其他需披露的发股协议或交易安排。
公司确认，其公众持股比例符合香港联合交易所有限公司的相关规定。月报由公司联席公司秘书张巍签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.